NCT05382663View on ClinicalTrials.gov

The Jordan Study for End-Stage Renal Disease Subjects

NARecruitingINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions

End Stage Renal Disease

Interventions

DEVICE

Alio Device

Non-invasive device worn over vasculature.

Trial Locations (1)

11195

RECRUITING

Jordan Center for Pharmaceutical Research, Amman

All Listed Sponsors

lead

Alio, Inc.

INDUSTRY